{"name":"Artax Biopharma Inc","slug":"artax-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"AX-024.HCl","genericName":"AX-024.HCl","slug":"ax-024-hcl","indication":"Other","status":"phase_1"},{"name":"AX-158","genericName":"AX-158","slug":"ax-158","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AX-024.HCl","genericName":"AX-024.HCl","slug":"ax-024-hcl","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AX-158","genericName":"AX-158","slug":"ax-158","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5mYWpBQ19UY2xhNHJJTHRlT1FfZE5mSDJIN3FhZkY0NU5pRHBhR0xjazR1Z2UzQWlmYlVKX1JXN0ZvQ08wOEtPQzVLNEVqUHBEVTYzdUZuSW5CUnVWT18yRHhBcU15b0J6emlGNA?oc=5","date":"2026-01-01","type":"pipeline","source":"Dermatology Times","summary":"Drugs to Watch in 2026 - Dermatology Times","headline":"Drugs to Watch in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNanMzWUFyck9qZjlmMG9ITEc1UVA1ZXlQcTl2LUlfcE1ESzVwNlFpRTJRN2FHcWNJMDZHTE02WjRFWXBvOFZ3bzdXS3pfZG54eklFaU1HcVpPdGlIZmh2X1pZcldmM2pvYmVxbFpKUFE0NkJKMXM4SFhBUG1aSnpXdWd0NnhWZ0JLb3c?oc=5","date":"2025-12-11","type":"pipeline","source":"Dermatology Times","summary":"Transformative Advances This Year and Beyond - Dermatology Times","headline":"Transformative Advances This Year and Beyond","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQdEFnQktFM210eXdiZmRhVlE4Y3FUTndfak5Cell5OFgyR1Z1QWxsaks4TzU0NTBvZlJIc0o3enpwWTlTYXBFR3o4eFZNZUg2QUpEZGN5Z3ZsTFRqTmZOMVBSZVpoa1YxT3ZHbFlaVVJOZHBWZjFkSE1jSFpXSVVpYVl2U1VhSHRJS1daVHZkSHAtLW5nbW1aeWZIZk9CQUxLNnVlYVF6VVZNRVdtT3ZpVzhMVkI1ODFPLUpqLWpBU3dEVnpWSldBX1JaTmZaX1VTUFJEc0hubWtXZGVwWmw4UmlyLUpTbk5MYVhCRENwaVByRVhzZXhobF9wUGJNYzUtMGNzWEFqbkN3enFKdFplVjJnYzVPQVduMDAzZ1Jn?oc=5","date":"2025-12-08","type":"regulatory","source":"GlobeNewswire","summary":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma - GlobeNewswire","headline":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQV2Mzd3U4MDJLX25lZGxDTUxoTmpKSGx4VEhMWlhWYTRMVjRHTFhDM1lwRjhyWVlzWVpjcEl2VnFjSVptVUZvaWFwVFpkeURjVEdzc3VXUFFJYWdiMEZnazRKUjFiT0VSaktGN09BMGhRc0xhTkxiUU5HQi1Vb0ZqLTUwV19QY0tmeWNLalBHSmVlZDJwUVRQT2s3SmZjbXNWR3FDMTJiNm1rSGJuYklFcEtnOVRrSF8wa29RWFhKZ3g1d0ZYQ1dn?oc=5","date":"2025-07-01","type":"regulatory","source":"Healio","summary":"Latest from FDA: Zoryve foam, more psoriasis biosimilars, Keytruda for skin cancer - Healio","headline":"Latest from FDA: Zoryve foam, more psoriasis biosimilars, Keytruda for skin cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPejI4bUhWenlJOG9CR3UtNHJXamI4TXhLbGRaY2stczUzVlBYd3hUWXFYX0E1cG1VTnFrS3ZOVlJTb1FkYjM2ZDM1SFlEdjgxXzVfVzhET1dpUllJaVE3c3MzTzh6b3ZYQzFUYjlDYmdlZFZ5RWR4bm03Nkh3NlQ0NjFuSzBwbjNiSEVlWEV6aDltUmtqU1dQMHFQWlR5U0taTjFZUWFoZnNOSG5wMncyclJ0YWdzSjdyRVIwag?oc=5","date":"2025-03-11","type":"pipeline","source":"Healio","summary":"‘Coming to the clinic soon’: Top AAD takeaways from Joel M. Gelfand, MD, MSCE - Healio","headline":"‘Coming to the clinic soon’: Top AAD takeaways from Joel M. Gelfand, MD, MSCE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOLTZtcnhNX0E3bEM4N1N2bWkxQzdaejU2MmUzTHhYRDJZd2RCR3JLSmJlSktZRWRRaWZscEtSR3J4ZFBfXzNIQmNmLUdZbGJQbldTVjBSRjBTbVpJU1JWTEcybVBvclZsNHpSOWRSMW5MMVpDQUwyRG1hdm1fbk9JejB4OS1XUnpZYkRxbFBxUFUyVnN1OU02SDVWbGxFS25oMHRzQkdDZmNMQ2RCVy1rZTNlYVZBYWc?oc=5","date":"2024-10-04","type":"trial","source":"Endpoints News","summary":"After $14B exit, Karuna co-founder finds next bet; Ex-Regenxbio CEO Ken Mills heads to Tagworks - Endpoints News","headline":"After $14B exit, Karuna co-founder finds next bet; Ex-Regenxbio CEO Ken Mills heads to Tagworks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPYWhTTl9zYXZ5MEx2VFNEck41TEZobEJSUldiWk8ybzU5RWx1VHB5WG5SMk84Mi1SQ194TEZlTGE1TEdObWdkN3hVN1hZTmhRcTBZb29uNjNoMVVlSE5wZnBtMnd5UVhGeng4QWRKSlF1aEZUdXhzdDFTbFFORUk2Q2Z5MjVjSHE0SGxERndsaWxqcWxXem8yajBoRGY2eUxhSG1XVWJ6Ty0yOG5RVzNYS1JUNTBJbUR6YzRUNjBmNHFLcUhDM0RxM2xIQQ?oc=5","date":"2024-08-06","type":"trial","source":"PR Newswire","summary":"Artax Biopharma Raises $8 Million Ahead of Phase 2a Data Expected in Q4-2024 - PR Newswire","headline":"Artax Biopharma Raises $8 Million Ahead of Phase 2a Data Expected in Q4-2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNM0M0ajlINWl6ZndORWQxTlg1dDUyejByWkR6algxQzFaXzhuTldXSDE3ZklWbzNacDlGU2dTUVlQWlA5UzRiZDNFT1phLVNjb3lBQk9OUUZNdlZLQkl4b01Ham5qVnUycnZicHFYRy1NcWZYZ29WenRna3NDWWNJMkJ6enI1SmFEblRnZy02RWN4b1JmVDl3ZlZfdVFwaHVrcVNScnktczJjN3hxejJRQ0lYQjJ3RFRKQWh3U1RNT0p4V2JzdHlQbkwyd29aR3hKbUhJS0N3TnNCX1hzSXRuTC03Q3JTNzdIUXYzdDh6Z3E2ckM1ZW4tZnVzZHhXYm11alZUSF9rVjR3SGZ2Z1N0UG9n?oc=5","date":"2022-05-11","type":"pipeline","source":"PR Newswire","summary":"Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases - PR Newswire","headline":"Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWlVGUk45b0t1cWdnVlZhZTVHaE5ySHlKX0tnSEtmM0U4ZEFkdU1Rdjc0dUdXUnFBdHk0VVN3X1ppZmd0bHdvUy1SaHlQbmpHMms2NDB0ZWk1MnlYQmh1dDE2bDdRc2NWU2pMLUJZUm9RbUZFLVd0WUlyMlA5R09rMVZ4V3d3NGtWR2lPa0hpN21UM1NOOWRMdUEwUUdqd18yUjh3OFJrU3k?oc=5","date":"2020-01-08","type":"pipeline","source":"statnews.com","summary":"A new biotechnology and pharmaceutical industry commitment to patients and the public - statnews.com","headline":"A new biotechnology and pharmaceutical industry commitment to patients and the public","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}